Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

vTv Therapeutics Inc.

NASDAQ: VTVTHealthcare / Biotechnology / USA
1.82-0.08-4.21%Vol 104 2281Y Perf -57.01%
Dec 12th, 2018 15:59
BID1.80 ASK1.87
Open1.86 Previous Close1.90
Pre-Market1.70 After-Trading1.88
 -0.20 -10.53%  0.06 3.30%
Target Price
3.00 
Analyst Rating
Hold 3.00
Potencial %
64.84 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)74 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
15.10 
Earnings Date
7th Nov 2018

Today's Price Range

1.781.90

 

52wk Range

0.658.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-21.16%
3 Months
102.13%
6 Months
0.53%
1 Year
-57.01%
3 Years
-71.77%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTVT1.82-0.0800-4.21
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.10
Current Ratio
0.20
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-9.30
Leverage Ratio -0.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-389.30
EBITDA Margin
-387.40
Pre-tax Profit Margin
-8 484.90
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
-
PS Ratios
10.10
Price to Cash Flow
-
Price to Free Cash Flow
-3.00
Cash Flow Per Share
-2.61
Price to Tangible Book
-1.87
Book Value per Share
-1.03
Enterprise Value (in ths.)
96 710
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
12.85
ROE last 12 Months
12.35
Return on Assets (5Y Avg)
-164.24
ROA last 12 Months
-63.35
Return on Capital (5Y Avg)
-
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.10
Receivables Turnover
4.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
8 145
Revenue per Share
0.19
Revenue Growth 3 Years
58.43
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.15-0.0660.00
Q02 2018-0.25-0.29-16.00
Q01 2018-0.35-0.3014.29
Q04 2017-0.41-0.44-7.32
Q03 2017-0.40-0.385.00
Q02 2017-0.46-0.4110.87
Q01 2017-0.46-0.444.35
Q04 2016-0.14-0.42-200.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.1131.25Positive
12/2018 QR-0.1611.11Positive
12/2018 FY-0.7320.65Positive
12/2019 FY-0.67-6.35Negative
Next Report Date-
Estimated EPS Next Report-0.15
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume104 228
Shares Outstanding (in ths.)40 750
Trades Count224
Dollar Volume181 022
Avg. Volume1 388 999
Avg. Weekly Volume134 559
Avg. Monthly Volume236 230
Avg. Quarterly Volume3 043 897

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

65%35%

Bearish Bullish

66%34%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News